Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling



Rating:

Share or cite this content

Citations should be made in the following way:
R. Strieter (Los Angeles, United States of America). The contribution of bone marrow derived progenitor cells to lung remodelling. Lung Science Conference 2008 - Lung Injury, Repair and Remodelling

Member's Comments

No comment yet.

Related content which might interest you: In vivo chracterization of bone marrow derived progenitor cells in airway remodeling in murine asthma model Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Bone marrow derived mesenchymal stem cells accelerate alveolar epithelial repair in vitro Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007 HGF expressing stem cells in the human fibrotic lung originate from the bone marrow Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both? Year: 2011 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Investigation of the participation of bone marrow derived cells in pulmonary angiogenesis and vascular remodeling Source: Eur Respir J 2002; 20: Suppl. 38, 481s Year: 2002 Bone marrow progenitor cells in patients with COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Phenotypical and molecular characteristics of bone marrow mesenchymal stem cells in rheumatoid lung Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Alterations of bone marrow derived endothelial progenitor cells following acute pulmonary embolism in mice Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 HGF expressing stem cells in usual interstitial pneumonia originate from the bone marrow and are antifibrotic Source: Research Seminar 2014 - The many faces of stem cells in respiratory diseases Year: 2014 Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Functional characterisation of bone marrow-derived mesenchymal stromal cells from COPD patients Source: ERJ Open Res 2016: 00045-2015 Year: 2016 Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 The role of bone-marrow derived adult stem cells in asthmatic airway remodeling Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma Source: Eur Respir J 2011; 38: 679-687 Year: 2011 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2008 - Pathophysiology of acute lung injury Year: 2008